SynthesisLasers in medical science2025
Impact of photobiomodulation in the management of medication-related osteonecrosis of the jaw : a systematic review.
Synthesis in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication-related osteonecrosis of the jaw (MRONJ) are localized aggressive necrotic bone complications occurring post-tooth avulsion in patients receiving bone antiresorptive agents. Photobiomodulation is used in the medical field for its ability to accelerate wound healing. This study aimed to evaluate the efficacy of photobiomodulation in the prevention or management of MRONJ. A systematic review following the PRISMA guidelines was performed across the databases PubMed, Science Direct, Scopus, Cochrane, Lilacs, and Google Scholar. The review was registered on Prospero under the number CRD42024581951. A total of 947 articles were screened, from which 10 were included in this systematic review. For Group A, the 5 cohorts found a MRONJ incidence of 0,93% (IC[1,3%-3,4%]) at a mean follow-up of 15 months. For Group B, the 3 cohorts identified clinical improvement for all lesions, with complete healing rates reaching up to 91.67% (IC[54.57%-68.34%]). The 3 non-randomized studies found a significant difference favoring photobiomodulation for clinical improvement, but only 2 studies reported a significant difference for complete healing. The studies presented various clinical application protocols, yet converged on the use of a laser with a wavelength greater than 980 nanometers, continuous emission, single-point application, over 8 sessions, with a session duration of 5 min. No adverse effects were reported. Photobiomodulation may reduce the incidence of MRONJ following tooth avulsions, and could improve their treatment (decreasing treatment time and improving prognosis). Further randomized, double-blind, studies are necessary to consolidate these results.
Indexed as
Identifiers
41398507What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.